210 related articles for article (PubMed ID: 33150819)
21. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
23. Childhood de novo CD5+ Diffuse Large B-cell Lymphoma: a Separate Entity?
Coffey A; Allen A; Thomsen MB; Sulis ML; Murty V; Hoehn D
Ann Clin Lab Sci; 2015; 45(5):574-81. PubMed ID: 26586711
[TBL] [Abstract][Full Text] [Related]
24. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
25. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O
Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
Nanya M; Sato M; Tanimoto K; Tozuka M; Mizutani S; Takagi M
PLoS One; 2015; 10(12):e0144540. PubMed ID: 26657054
[TBL] [Abstract][Full Text] [Related]
27. The role of constitutive activation of FMS-related tyrosine kinase-3 and
Fedders H; Alsadeq A; Schmäh J; Vogiatzi F; Zimmermann M; Möricke A; Lenk L; Stadt UZ; Horstmann MA; Pieters R; Schrappe M; Stanulla M; Cario G; Schewe DM
Haematologica; 2017 Nov; 102(11):e438-e442. PubMed ID: 28838992
[No Abstract] [Full Text] [Related]
28. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
[TBL] [Abstract][Full Text] [Related]
29. C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.
Marneth AE; Prange KHM; Al Hinai ASA; Bergevoet SM; Tesi N; Janssen-Megens EM; Kim B; Sharifi N; Yaspo ML; Kuster J; Sanders MA; Stoetman ECG; Knijnenburg J; Arentsen-Peters TCJM; Zwaan CM; Stunnenberg HG; van den Heuvel-Eibrink MM; Haferlach T; Fornerod M; Jansen JH; Valk PJM; van der Reijden BA; Martens JHA
Leukemia; 2018 Mar; 32(3):828-836. PubMed ID: 28871137
[TBL] [Abstract][Full Text] [Related]
30. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
Liu J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Cheng YF; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
Ann Hematol; 2021 May; 100(5):1267-1281. PubMed ID: 33712867
[TBL] [Abstract][Full Text] [Related]
31. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
[TBL] [Abstract][Full Text] [Related]
32. Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma.
Schafernak KT; Williams JA; Clyde BI; Marcus C; Decker B; Toydemir RM
Cancer Genet; 2021 Nov; 258-259():23-26. PubMed ID: 34237703
[TBL] [Abstract][Full Text] [Related]
33. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
34. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia.
Sharma R; Incoronato A; Zhang C; Jayanthan A; Shah R; Narendran A
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e750-e756. PubMed ID: 37494611
[TBL] [Abstract][Full Text] [Related]
36. Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases.
Yoshimi A; Kato K; Hosaka S; Suzuki R; Fukushima H; Nakao T; Kobayashi C; Fukushima T; Koike K; Sumazaki R; Tsuchida M
Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28332262
[TBL] [Abstract][Full Text] [Related]
37. CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.
Collins K; Cardinali JL; Mnayer LO; DiGiuseppe JA
Cytometry B Clin Cytom; 2021 Mar; 100(2):243-248. PubMed ID: 31894899
[TBL] [Abstract][Full Text] [Related]
38. Rare
Panagopoulos I; Andersen K; Eilert-Olsen M; Rognlien AG; Munthe-Kaas MC; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(2):121-131. PubMed ID: 33608309
[TBL] [Abstract][Full Text] [Related]
39. Romidepsin enhances the efficacy of cytarabine
Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
[No Abstract] [Full Text] [Related]
40. Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia.
Isobe T; Takagi M; Sato-Otsubo A; Nishimura A; Nagae G; Yamagishi C; Tamura M; Tanaka Y; Asada S; Takeda R; Tsuchiya A; Wang X; Yoshida K; Nannya Y; Ueno H; Akazawa R; Kato I; Mikami T; Watanabe K; Sekiguchi M; Seki M; Kimura S; Hiwatari M; Kato M; Fukuda S; Tatsuno K; Tsutsumi S; Kanai A; Inaba T; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Kotecha RS; Cruickshank MN; Ishikawa F; Morio T; Eguchi M; Deguchi T; Kiyokawa N; Arakawa Y; Koh K; Aoki Y; Ishihara T; Tomizawa D; Miyamura T; Ishii E; Mizutani S; Wilson NK; Göttgens B; Miyano S; Kitamura T; Goyama S; Yokoyama A; Aburatani H; Ogawa S; Takita J
Nat Commun; 2022 Aug; 13(1):4501. PubMed ID: 36042201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
